Lori McNeill

Lori McNeill is a declared insider of Sonnet BioTherapeutics Holdings, Inc., with filings sourced from SEC (Form 4). We count 4 filings; the first trade dates from 14 December 2022 and the latest from 2 December 2025.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The record was last updated on 3 December 2025 with a transaction in Sonnet BioTherapeutics Holdings, Inc. Typically, a trade is published a median of 6 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.